KG
BSX icon

Kilter Group’s Boston Scientific BSX Stock Holding History

Kilter Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
352
+73
+26% +$3.96K 0.01% 356
2026
Q1 		$17.5K Buy
279
+11
+4% +$880 0.01% 256
2025
Q4 		$25.6K Sell
268
-6
-2% -$588 0.01% 180
2025
Q3 		$26.8K Sell
274
-5
-2% -$518 0.01% 165
2025
Q2 		$30K Buy
+279
New +$28.2K 0.01% 136

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kilter Group's BSX Position: Q2 2026 in Review

Kilter Group increased its Boston Scientific (BSX) stake by 26% in Q2 2026, buying an estimated $3.96K and bringing the position to 352 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #356.

Kilter Group first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $30K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kilter Group held 352 shares of Boston Scientific worth $15K as of Q2 2026.
  • Kilter Group bought 73 Boston Scientific shares in Q2 2026, an estimated $3.96K.
  • Boston Scientific made up 0.01% of Kilter Group's portfolio in Q2 2026, its #356 holding.
  • Kilter Group first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Boston Scientific position peaked at $30K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.